Allergan Bid Approaches $53 Billion

Valeant Pharmaceuticals boosted its takeover bid for Botox-maker Allergan for the second time this week, offering about $52.7 billion in cash and stock, partly thanks to its partner in the bid, William Ackman, offering to take a price cut on his own Allergan shares.